KG Bio

Bringing Biologics Medical Innovation to International Market

Jakarta, Indonesia · Founded 2015 · $55.0M raised

Headquarters
Jakarta
Founded
2015
Business Model
B2B
Total Funding
$55.0M
Last Round
$55.0M Series CJan 2021
Rounds
1

About

KGbio (PT Kalbe Genexine Biologics) is a clinical-stage biotechnology company backed by Kalbe Farma of Indonesia and Genexine of South Korea, formed as a joint venture in 2015. It focuses on in-licensing and out-licensing biologics and biosimilars in oncology and other high-specialty therapeutic areas, and also provides cGMP contract development and manufacturing services as a pioneer of biopharmaceutical CDMO work in Indonesia.

Summary

KG Bio is a Life Sciences company based in Jakarta, Indonesia, founded in 2015. It has raised $55.0M in total across 1 round, most recently a $55.0M Series C round in Jan 2021. Investors include General Atlantic.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2021
$55.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

KG Bio on Indexed.vc
<a href="https://indexed.vc/companies/kalbe-genexine-biologics"><img src="https://indexed.vc/api/badge/company/kalbe-genexine-biologics" alt="KG Bio on Indexed.vc" width="260" height="76" /></a>